Patterns of Care for Medicare Beneficiaries With Metastatic Prostate Cancer.

Christopher P FilsonThomas B RichardsDonatus U EkwuemeDavid H Howard

Published in: Urology practice (2024)

Most metastatic prostate cancer patients do not receive life-prolonging antineoplastic therapies. Improved adoption of effective cancer therapies when appropriate may increase length and quality of survival among metastatic prostate cancer patients.

Keyphrases

prostate cancer
squamous cell carcinoma
small cell lung cancer
radical prostatectomy
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
quality improvement
peritoneal dialysis
papillary thyroid
electronic health record
pain management
young adults